Locus Pharmaceuticals

About:

Locus Pharmaceuticals develops a drug design and development platform for oral drug therapies in the areas of unmet medical needs.

Website: http://locuspharma.com

Top Investors: SR One, Johnson & Johnson Development Corporation, Prism Venture Management, HBM Healthcare Investments, Tredegar Investments

Description:

Locus Pharmaceuticals, Inc. develops a drug design and development platform for oral drug therapies in the areas of unmet medical needs. Its fragment-based computational drug design technology is used for the discovery and development of compounds for the treatment of unmet medical needs. The company has a computational drug design technology, which is used to develop a pipeline of drug development candidates, including direct and allosteric kinase inhibitors for cancer and inflammation diseases. Locus Pharmaceuticals, Inc. was formerly known as Locus Discovery, Inc. The company was incorporated in 1998 and is based in Blue Bell, Pennsylvania. Locus Pharmaceuticals, Inc. is a former subsidiary of Sarnoff Corporation.